These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Histone Deacetylase 9 Activates IKK to Regulate Atherosclerotic Plaque Vulnerability. Asare Y; Campbell-James TA; Bokov Y; Yu LL; Prestel M; El Bounkari O; Roth S; Megens RTA; Straub T; Thomas K; Yan G; Schneider M; Ziesch N; Tiedt S; Silvestre-Roig C; Braster Q; Huang Y; Schneider M; Malik R; Haffner C; Liesz A; Soehnlein O; Bernhagen J; Dichgans M Circ Res; 2020 Aug; 127(6):811-823. PubMed ID: 32546048 [TBL] [Abstract][Full Text] [Related]
3. Research Progress on Histone Deacetylases Regulating Programmed Cell Death in Atherosclerosis. Zhou G; Liu Y; Wu H; Zhang D; Yang Q; Li Y J Cardiovasc Transl Res; 2024 Apr; 17(2):308-321. PubMed ID: 37821683 [TBL] [Abstract][Full Text] [Related]
4. Role of histone deacetylases in vascular cell homeostasis and arteriosclerosis. Zhou B; Margariti A; Zeng L; Xu Q Cardiovasc Res; 2011 Jun; 90(3):413-20. PubMed ID: 21233251 [TBL] [Abstract][Full Text] [Related]
5. The important role of histone deacetylases in modulating vascular physiology and arteriosclerosis. Zhao TC; Wang Z; Zhao TY Atherosclerosis; 2020 Jun; 303():36-42. PubMed ID: 32535412 [TBL] [Abstract][Full Text] [Related]
6. Posttranslational modifications of histone deacetylases: implications for cardiovascular diseases. Eom GH; Kook H Pharmacol Ther; 2014 Aug; 143(2):168-80. PubMed ID: 24594235 [TBL] [Abstract][Full Text] [Related]
7. Rho-GTPase and Atherosclerosis: Pleiotropic Effects of Statins. Cai A; Zhou Y; Li L J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124206 [No Abstract] [Full Text] [Related]
9. Histone Deacetylases (HDACs) and Atherosclerosis: A Mechanistic and Pharmacological Review. Chen X; He Y; Fu W; Sahebkar A; Tan Y; Xu S; Li H Front Cell Dev Biol; 2020; 8():581015. PubMed ID: 33282862 [TBL] [Abstract][Full Text] [Related]
10. The regulatory role of DPP4 in atherosclerotic disease. Duan L; Rao X; Xia C; Rajagopalan S; Zhong J Cardiovasc Diabetol; 2017 Jun; 16(1):76. PubMed ID: 28619058 [TBL] [Abstract][Full Text] [Related]
11. Epigenetics in vascular disease - therapeutic potential of new agents. Xu SS; Alam S; Margariti A Curr Vasc Pharmacol; 2014 Jan; 12(1):77-86. PubMed ID: 22724461 [TBL] [Abstract][Full Text] [Related]
12. Inhibiting epigenetic enzymes to improve atherogenic macrophage functions. Van den Bossche J; Neele AE; Hoeksema MA; de Heij F; Boshuizen MC; van der Velden S; de Boer VC; Reedquist KA; de Winther MP Biochem Biophys Res Commun; 2014 Dec; 455(3-4):396-402. PubMed ID: 25446073 [TBL] [Abstract][Full Text] [Related]
14. The biology and therapeutic implications of HDACs in the heart. McKinsey TA Handb Exp Pharmacol; 2011; 206():57-78. PubMed ID: 21879446 [TBL] [Abstract][Full Text] [Related]